SHAWNEE THOMAS: Open Payments
NPI 1952814204 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 33 payments from 12 companies in 2025. Trend: 2023 $973 · 2024 $688 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $414 |
| Lilly USA, LLC | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Astellas Pharma US Inc | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| Alkermes, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
Products named: QULIPTA, UBRELVY, MOUNJARO, AIRSUPRA, Veozah, ARISTADA, Kerendia, TRELEGY ELLIPTA.
Industry payments across MD — which companies pay providers there.
